This opportunity is no longer accepting applications.
grant RFA-AI-24-017

Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)

This funding opportunity aims to support research on the connections between certain genetic regions (HLA and KIR) and diseases that are influenced by the immune system. The goals are to understand these connections better, explore the mechanisms behind them to find new treatments, and confirm these connections to enhance disease prediction in clinical settings.

The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, 2) elucidates mechanisms underlying th…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Awards & funding

Award Ceiling: $400,000
Award Amount: $400,000

Dates

Opportunity Released: April 23, 2024
Open for Submission: April 23, 2024
Submission Deadline: August 20, 2024
Application Window Closes: August 20, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.